Spotlight on Eli Lilly: Analyzing the Surge in Options Activity
Spotlight on Eli Lilly: Analyzing the Surge in Options Activity
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale trades within a strike price range from $430.0 to $960.0 in the last 30 days. Financial giants have made a conspicuous bearish move on Eli Lilly. Our analysis of options history for Eli Lilly (NYSE:LLY) revealed 12 unusual trades.
金融巨頭在Eli Lilly的股票上做出了明顯的看淡舉動。我們對Eli Lilly（紐交所: LLY）的期權交易歷史進行分析後發現了12筆飛凡交易。
Delving into the details, we found 41% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $77,554, and 10 were calls, valued at $1,136,535.
深入細節，我們發現41%的交易者持有看好態度，而50%表現出看淡傾向。在我們發現的所有交易中，有2筆看跌，價值爲$77,554，有10筆看漲，價值爲$1,136,535。
Predicted Price Range
預測價格區間
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $430.0 to $960.0 for Eli Lilly during the past quarter.
分析這些合約的成交量和未平倉合約數，似乎大型交易者在過去一個季度一直在關注Eli Lilly股票的價格區間從$430.0到$960.0。
Insights into Volume & Open Interest
成交量和持倉量分析
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale trades within a strike price range from $430.0 to $960.0 in the last 30 days.
在交易期權時，觀察成交量和未平倉合約數是一個強有力的舉措。這些數據可以幫助您跟蹤Eli Lilly期權在特定執行價格下的流動性和興趣。下面，我們可以觀察過去30天內Eli Lilly所有的大宗交易的看漲和看跌的成交量和未平倉合約數變化，涵蓋了從$430.0到$960.0的執行價格區間。
Eli Lilly Call and Put Volume: 30-Day Overview
Eli Lilly Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | BULLISH | 11/15/24 | $476.95 | $470.95 | $474.8 | $450.00 | $474.8K | 0 | 0 |
| LLY | CALL | TRADE | BULLISH | 12/20/24 | $55.5 | $53.75 | $55.5 | $930.00 | $210.9K | 26 | 38 |
| LLY | CALL | SWEEP | BEARISH | 09/27/24 | $13.15 | $11.0 | $11.0 | $920.00 | $111.1K | 262 | 20 |
| LLY | CALL | TRADE | BULLISH | 10/18/24 | $9.5 | $7.85 | $9.5 | $960.00 | $95.0K | 683 | 200 |
| LLY | CALL | TRADE | BEARISH | 09/27/24 | $2.1 | $1.75 | $1.75 | $950.00 | $52.5K | 1.2K | 278 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | 看漲 | 交易 | 看好 | 11/15/24 | $476.95 | $470.95 | $474.8 | $450.00 | $474.8K | 0 | 0 |
| LLY | 看漲 | 交易 | 看好 | 12/20/24 | $55.5 | $53.75 | $55.5 | $930.00 | 210.9K | 26 | 38 |
| LLY | 看漲 | SWEEP | 看淡 | 09/27/24 | $13.15 | $11.0 | $11.0 | $920.00 | 111.1K美元 | 262 | 20 |
| LLY | 看漲 | 交易 | 看好 | 10/18/24 | $9.5 | $7.85 | $9.5 | $960.00 | 95.0千美元 | 683 | 200 |
| LLY | 看漲 | 交易 | 看淡 | 09/27/24 | $2.1 | $1.75 | $1.75 | $950.00 | $52.5K | 1.2K | 278 |
About Eli Lilly
關於Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly是一家專注於神經科學，心臟代謝，癌症和免疫學的藥物公司。Lilly的主要產品包括用於治療癌症的Verzenio；用於心臟代謝的Mounjaro，Zepbound，Jardiance，Trulicity，Humalog和Humulin；以及用於免疫學的Taltz和Olumiant。
Having examined the options trading patterns of Eli Lilly, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
在研究完Eli Lilly的期權交易模式後，我們的注意力現在直接轉向公司本身。這種轉變使我們能夠深入探討其當前的市場地位和表現。
Current Position of Eli Lilly
Eli Lilly的當前位置
- Currently trading with a volume of 156,502, the LLY's price is down by -0.22%, now at $919.48.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 37 days.
- 目前成交量爲156,502，LLY的價格下跌了-0.22%，目前爲$919.48。
- RSI讀數表明該股票目前處於中立狀態，處於超買和超賣之間。
- 預計37天后公佈收益。
Professional Analyst Ratings for Eli Lilly
Eli Lilly的專業分析師評級
In the last month, 5 experts released ratings on this stock with an average target price of $1007.2.
在過去一個月裏，5位專家發佈了對這隻股票的評級，平均目標價格爲$1007.2。
Turn $1000 into $1270 in just 20 days?
在短短20天內，將1000美元變成1270美元？
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.* An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $885. * An analyst from Morgan Stanley downgraded its action to Overweight with a price target of $1106. * An analyst from JP Morgan persists with their Overweight rating on Eli Lilly, maintaining a target price of $1100. * Reflecting concerns, an analyst from Citigroup lowers its rating to Buy with a new price target of $1060.* Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $885.
20年期權交易專家揭示了他的單線圖技術，顯示何時買入和賣出。複製他的交易，平均每20天獲利27%。點擊這裏獲取訪問權限。* Cantor Fitzgerald 的分析師將行動評級降級爲超配，目標價爲$885。* 摩根士丹利的分析師將行動評級降級爲超配，目標價爲$1106。* JP摩根的分析師維持對 Eli Lilly 的超配評級，保持目標價爲$1100。* 反映擔憂，花旗集團的分析師將評級降至買入，新目標價爲$1060。* 反映擔憂，Cantor Fitzgerald的分析師將評級降至超配，新目標價爲$885。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。
譯文內容由第三人軟體翻譯。